NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Collections Health Policy and Services Research Remove constraint Collections: Health Policy and Services Research Subjects Cost-Benefit Analysis Remove constraint Subjects: Cost-Benefit Analysis Languages English Remove constraint Languages: English

Search Results

21. Mepolizumab (Nucala??, GlaxoSmithKline plc.) for the treatment of severe asthma with eosinophilia: effectiveness, value, and value-based price benchmarks : final report

22. Insulin degludec (Tresiba??, Novo Nordisk A/S) for the treatment of diabetes: effectiveness, value, and value-based price benchmarks : final report

23. Controversies in migraine management: a technology assessment : final report

27. Controversies in obesity management: a technology assessment : final report